ARCHIVES

Volasertib and LDAC Doubled Response in Older Patients

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

NAB Report To President Makes Pitch for Money, Cites Research Progress

August 9, 1974

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

Local University Competing for Part FCRF Contract

December 4, 1981

Van Potter Wins Bristol-Myers Award

April 24, 1981